These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11152899)

  • 21. [Medical abortion using methotrexate and misoprostol. Efficacy and tolerability].
    Iamakov K; Pekhlivanov B; Amaliev I
    Akush Ginekol (Sofiia); 2005; 44(3):16-8. PubMed ID: 16028385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A viable alternative to surgical vacuum aspiration: repeated doses of intravaginal misoprostol over 9 hours for medical termination of pregnancies up to eight weeks.
    Singh K; Fong YF; Dong F
    BJOG; 2003 Feb; 110(2):175-80. PubMed ID: 12618162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early medical termination pregnancy with methotrexate and misoprostol in lower segment cesarean section cases.
    Gautam R; Agrawal V
    J Obstet Gynaecol Res; 2003 Aug; 29(4):251-6. PubMed ID: 12959148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methotrexate and misoprostol for early abortion in adolescent women.
    Creinin MD; Wiebe E; Gold M
    J Pediatr Adolesc Gynecol; 1999 May; 12(2):71-7. PubMed ID: 10326191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical abortion outcomes after a second dose of misoprostol for persistent gestational sac.
    Reeves MF; Kudva A; Creinin MD
    Contraception; 2008 Oct; 78(4):332-5. PubMed ID: 18847584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors related to successful misoprostol treatment for early pregnancy failure.
    Creinin MD; Huang X; Westhoff C; Barnhart K; Gilles JM; Zhang J;
    Obstet Gynecol; 2006 Apr; 107(4):901-7. PubMed ID: 16582130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on early medical and surgical abortion.
    Westfall JM; O'Brien-Gonzales A; Barley G
    J Womens Health; 1998 Oct; 7(8):991-5. PubMed ID: 9812295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate pharmacokinetics and effects in women receiving methotrexate 50 mg and 60 mg per square meter for early abortion.
    Creinin MD; Krohn MA
    Am J Obstet Gynecol; 1997 Dec; 177(6):1444-9. PubMed ID: 9423749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical abortion with oral methotrexate and vaginal misoprostol.
    Creinin MD; Vittinghoff E; Schaff E; Klaisle C; Darney PD; Dean C
    Obstet Gynecol; 1997 Oct; 90(4 Pt 1):611-6. PubMed ID: 9380325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abortion induced with methotrexate and misoprostol.
    Wiebe ER
    CMAJ; 1996 Jan; 154(2):165-70. PubMed ID: 8548705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Menstrual Age on Failure of Medical Management in Women With Early Pregnancy Loss.
    Lavecchia M; Abenhaim HA
    J Obstet Gynaecol Can; 2015 Jul; 37(7):617-623. PubMed ID: 26366818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timing and indication for curettage after medical abortion in early pregnant women with prior uterine incision.
    Wang G; Li D; Manconi F; Dong B; Zhang Y; Sun B
    Contraception; 2010 Jan; 81(1):62-6. PubMed ID: 20004275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical abortion at first trimester of pregnancy with misoprostol.
    Ayati S; Roudsari FV; Khadem N; Shakeri MT
    Saudi Med J; 2008 Dec; 29(12):1739-42. PubMed ID: 19082224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simplified medical abortion screening: a demonstration project.
    Raymond EG; Tan YL; Comendant R; Sagaidac I; Hodorogea S; Grant M; Sanhueza P; Van Pratt E; Gillespie G; Boraas C; Weaver MA; Platais I; Bousieguez M; Winikoff B
    Contraception; 2018 Apr; 97(4):292-296. PubMed ID: 29170088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion? A retrospective analysis of 8678 abortions.
    Aldrich T; Winikoff B
    BJOG; 2007 May; 114(5):555-62. PubMed ID: 17439563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
    Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
    Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical abortion at 64 to 91 days of gestation: a review of 483 consecutive cases.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2003 May; 188(5):1315-9. PubMed ID: 12748505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study.
    Jensen JT; Harvey SM; Beckman LJ
    Am J Obstet Gynecol; 2000 Jun; 182(6):1292-9. PubMed ID: 10871441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.